- Investing Ideas
- Indian Pharmaceuticals & Biotech Large Cap High Growth Potential
Indian Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
Laurus Labs
Market Cap: ₹1.0t
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹1,866.20
7D
2.9%
1Y
114.8%
Torrent Pharmaceuticals
Market Cap: ₹1.9t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.
500420
₹4,920.00
7D
-1.1%
1Y
36.6%
Divi's Laboratories
Market Cap: ₹2.3t
Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
DIVISLAB
₹8,744.50
7D
1.8%
1Y
41.3%